ModelEdge

Landos Biopharma Inc.
LABP
Filing Type8-K
Filing Date5/22/2024
Updated5/23/24, 2:29 PM

Filing

8-K
Earnings Release

Exhibits

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
EX-3.1EX-3.1
EX-3.2EX-3.2
EX-99.1Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
GRAPHICGraphic